Maintenance Infos

Reply to M.C. Chamberlain

Stupp, R; Hegi, M E; Neyns, B; Goldbrunner, R; Schlegel, U; Clement, P M J; Grabenbauer, G G; Ochsenbein, A F; Simon, M; Dietrich, P Y; Pietsch, T; Hicking, C; Tonn, J C; Diserens, A C; Pica, A; Hermisson, M; Krueger, S; Picard, M; Weller, M (2010). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 28(33):e696-e697.



2 downloads since deposited on 28 Jan 2011
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Deposited On:28 Jan 2011 17:19
Last Modified:05 Apr 2016 14:40
Publisher:American Society of Clinical Oncology
Additional Information:Reply to: Chamberlain, M C. What role should cilengitide have in the treatment of glioblastoma? J Clin Oncol. 2010 Nov 20;28(33):e695
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:10.1200/JCO.2010.31.2843
Permanent URL:


Filetype: PDF (Verlags-PDF) - Registered users only
Size: 1MB
View at publisher

Author Collaborations